Acute Severe Ulcerative Colitis Clinical Trials in Xianyang, Shaanxi
2 recruitingXianyang, Shaanxi, China
Showing 1–2 of 2 trials
Recruiting
Phase 4
Upadacitinib Versus Infliximab as Second-Line Treatment for Acute Severe Ulcerative Colitis（UPRISE）
Acute Severe Ulcerative Colitis
Xijing Hospital of Digestive Diseases226 enrolled4 locationsNCT07550673
Recruiting
Phase 4
Comparative Effectiveness of Upadacitinib vs Corticosteroids as First-Line Therapy for Acute Severe Ulcerative Colitis（UPFRONT）
Acute Severe Ulcerative Colitis
Yongquan Shi46 enrolled4 locationsNCT07546097